The Urea–Creatinine Ratio as Marker of Catabolism Is Affected by Continuous Renal Replacement Therapy
Diagnostics · 01.06.2025 · 15 (11) · 1408
DOI: 10.3390/diagnostics15111408 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 01.06.2025. Verfasst von Andreas Markl-Le Levé und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
An elevated urea–creatinine ratio (UCR) is used as a surrogate for catabolism and elevated protein metabolism in critically ill patients. This study investigated the effect of continuous renal replacement therapy (CRRT) on UCR.
Methods
In this retrospective single-centre study, ICU patients from 2011 to 2022 with an ICU stay >2 days before CRRT and a CRRT duration of ≥4 days were included. Patients were grouped by UCR at CRRT initiation into high (UCR ≥ 75 mg/dL:mg/dL) and low groups and compared to matched controls not requiring CRRT. Propensity score matching considered age, sex, bodyweight, SAPS3, SOFA score, and UCR values on baseline and pre-baseline days.
Results
In the high UCR group, UCR significantly decreased after CRRT initiation, reaching a significant difference from controls on day 2 (85.0 [IQR: 69.5–96.4] vs. 94.4 [IQR: 83.0–115.2]; p = 0.036) and falling below the threshold of 75 by day 3. In the low group, UCR increased post-CRRT initiation, but was less pronounced than in controls, with significant differences on day 1 (44.0 [IQR: 34.2–59.8] vs. 40.6 [IQR: 32.1–52.5]; p = 0.024).
Conclusions
CRRT significantly affects UCR in critically ill patients, showing a marked decrease when compared to matched controls.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
ORCID-Profile: Andreas Markl-Le Levé, Stefan Schmid, Christopher Rugg
Zitieren
APA
Markl-Le Levé, A., Hillinger, P., Woyke, S., Ronzani, M., Schmid, S., Kreutziger, J., & Rugg, C. (2025). The Urea–Creatinine Ratio as Marker of Catabolism Is Affected by Continuous Renal Replacement Therapy. Diagnostics, 15(11), 1408. https://doi.org/10.3390/diagnostics15111408
Vancouver
Markl-Le Levé A, Hillinger P, Woyke S, Ronzani M, Schmid S, Kreutziger J, et al. The Urea–Creatinine Ratio as Marker of Catabolism Is Affected by Continuous Renal Replacement Therapy. Diagnostics. 2025;15(11):1408. doi:10.3390/diagnostics15111408
BibTeX
@article{MarklLeLev2025,
author = {Markl-Le Levé, Andreas and Hillinger, Petra and Woyke, Simon and Ronzani, Marco and Schmid, Stefan and Kreutziger, Janett and Rugg, Christopher},
title = {The Urea–Creatinine Ratio as Marker of Catabolism Is Affected by Continuous Renal Replacement Therapy},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {11},
pages = {1408},
doi = {10.3390/diagnostics15111408}
}
EUVIMED